Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.19% |
| 2 | Financials | 11.87% |
| 3 | Industrials | 10.26% |
| 4 | Energy | 9.33% |
| 5 | Technology | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLTH
2526
DELISTED
Nobilis Health Corp.
HLTH
| $644K | ﹤0.01% |
+306,543
| New | +$834K |
|
2527
Barnes & Noble Education
BNED
$440M
| $642K | ﹤0.01% |
560
-2,086
| -79% | -$2.2M |
|
|
EAD
2528
Allspring Income Opportunities Fund
EAD
$372M
| $641K | ﹤0.01% |
+75,545
| New | +$617K |
|
2529
Oxford Industries
OXM
$596M
| $640K | ﹤0.01% |
10,648
-215,574
| -95% | -$14.2M |
|
2530
Stagwell
STGW
$1.92B
| $639K | ﹤0.01% |
97,600
-79,378
| -45% | -$587K |
|
2531
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.26B
| $637K | ﹤0.01% |
+10,409
| New | +$658K |
|
2532
Provident Financial Services
PFS
$3.12B
| $636K | ﹤0.01% |
+22,456
| New | +$559K |
|
2533
iShares MSCI USA Quality Factor ETF
QUAL
$46B
| $636K | ﹤0.01% |
9,207
+2,857
| +45% | +$194K |
|
|
TTPH
2534
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $634K | ﹤0.01% |
7,871
+977
| +14% | +$77.3K |
|
2535
Option Care Health
OPCH
$3.43B
| $632K | ﹤0.01% |
151,958
+141,203
| +1,313% | +$1.08M |
|
|
TWNK
2536
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $632K | ﹤0.01% |
+48,643
| New | +$590K |
|
|
CMCM
2537
Cheetah Mobile
CMCM
$87.5M
| $631K | ﹤0.01% |
13,209
+7,786
| +144% | +$413K |
|
|
PRA
2538
DELISTED
ProAssurance
PRA
| $631K | ﹤0.01% |
11,228
-7,389
| -40% | -$409K |
|
2539
Cardiff Oncology
CRDF
$65.4M
| $630K | ﹤0.01% |
4,164
+3,834
| +1,162% | +$895K |
|
|
TSRO
2540
DELISTED
TESARO, Inc.
TSRO
| $630K | ﹤0.01% |
+4,684
| New | +$591K |
|
2541
Golub Capital BDC
GBDC
$3.34B
| $628K | ﹤0.01% |
34,840
+13,420
| +63% | +$240K |
|
|
FOLD
2542
DELISTED
Amicus Therapeutics
FOLD
| $627K | ﹤0.01% |
+126,091
| New | +$873K |
|
|
AYR
2543
DELISTED
Aircastle Ltd
AYR
| $627K | ﹤0.01% |
30,058
-259,758
| -90% | -$5.48M |
|
2544
Vera Bradley
VRA
$107M
| $625K | ﹤0.01% |
53,353
-7,035
| -12% | -$96.9K |
|
2545
CALL
Geron
GERN
$949M
| $621K | ﹤0.01% |
+300,000
| New | +$633K |
|
2546
LivePerson
LPSN
$20.3M
| $619K | ﹤0.01% |
+5,469
| New | +$676K |
|
2547
Theravance Biopharma
TBPH
$875M
| $619K | ﹤0.01% |
+19,420
| New | +$602K |
|
|
TWOU
2548
DELISTED
2U Inc
TWOU
| $619K | ﹤0.01% |
+684
| New | +$697K |
|
|
TMX
2549
DELISTED
Terminix Global Holdings, Inc.
TMX
| $619K | ﹤0.01% |
+24,542
| New | +$602K |
|
2550
First Bancorp
FBNC
$2.61B
| $618K | ﹤0.01% |
22,784
-52,664
| -70% | -$1.22M |
|
Similar funds
Millennium Management's Q4 2016 Portfolio in Review
As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Millennium Management withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.
Against the trend, Millennium Management opened a new position in Target worth $175M.
- Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Millennium Management opened 858 new positions and closed 801 in Q4 2016.
- Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.